169 related articles for article (PubMed ID: 32438682)
1. Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children.
Mateos MK; Tulstrup M; Quinn MC; Tuckuviene R; Marshall GM; Gupta R; Mayoh C; Wolthers BO; Barbaro PM; Ruud E; Sutton R; Huttunen P; Revesz T; Trakymiene SS; Barbaric D; Tedgård U; Giles JE; Alvaro F; Jonsson OG; Mechinaud F; Saks K; Catchpoole D; Kotecha RS; Dalla-Pozza L; Chenevix-Trench G; Trahair TN; MacGregor S; Schmiegelow K
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32438682
[TBL] [Abstract][Full Text] [Related]
2. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
Thibord F; Klarin D; Brody JA; Chen MH; Levin MG; Chasman DI; Goode EL; Hveem K; Teder-Laving M; Martinez-Perez A; Aïssi D; Daian-Bacq D; Ito K; Natarajan P; Lutsey PL; Nadkarni GN; de Vries PS; Cuellar-Partida G; Wolford BN; Pattee JW; Kooperberg C; Braekkan SK; Li-Gao R; Saut N; Sept C; Germain M; Judy RL; Wiggins KL; Ko D; O'Donnell CJ; Taylor KD; Giulianini F; De Andrade M; Nøst TH; Boland A; Empana JP; Koyama S; Gilliland T; Do R; Huffman JE; Wang X; Zhou W; Manuel Soria J; Carlos Souto J; Pankratz N; Haessler J; Hindberg K; Rosendaal FR; Turman C; Olaso R; Kember RL; Bartz TM; Lynch JA; Heckbert SR; Armasu SM; Brumpton B; Smadja DM; Jouven X; Komuro I; Clapham KR; Loos RJF; Willer CJ; Sabater-Lleal M; Pankow JS; Reiner AP; Morelli VM; Ridker PM; Vlieg AVH; Deleuze JF; Kraft P; Rader DJ; ; Min Lee K; Psaty BM; Heidi Skogholt A; Emmerich J; Suchon P; Rich SS; Vy HMT; Tang W; Jackson RD; Hansen JB; Morange PE; Kabrhel C; Trégouët DA; Damrauer SM; Johnson AD; Smith NL
Circulation; 2022 Oct; 146(16):1225-1242. PubMed ID: 36154123
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
[TBL] [Abstract][Full Text] [Related]
4. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
Tang W; Teichert M; Chasman DI; Heit JA; Morange PE; Li G; Pankratz N; Leebeek FW; Paré G; de Andrade M; Tzourio C; Psaty BM; Basu S; Ruiter R; Rose L; Armasu SM; Lumley T; Heckbert SR; Uitterlinden AG; Lathrop M; Rice KM; Cushman M; Hofman A; Lambert JC; Glazer NL; Pankow JS; Witteman JC; Amouyel P; Bis JC; Bovill EG; Kong X; Tracy RP; Boerwinkle E; Rotter JI; Trégouët DA; Loth DW; Stricker BHC; Ridker PM; Folsom AR; Smith NL
Genet Epidemiol; 2013 Jul; 37(5):512-521. PubMed ID: 23650146
[TBL] [Abstract][Full Text] [Related]
6. Is there still room for additional common susceptibility alleles for venous thromboembolism?
Trégouët DA; Delluc A; Roche A; Derbois C; Olaso R; Germain M; de Andrade M; Tang W; Chasman DI; van Hylckama Vlieg A; Reitsma PH; Kabrhel C; Smith N; Morange PE
J Thromb Haemost; 2016 Sep; 14(9):1798-802. PubMed ID: 27326655
[TBL] [Abstract][Full Text] [Related]
7. Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.
Crous-Bou M; De Vivo I; Camargo CA; Varraso R; Grodstein F; Jensen MK; Kraft P; Goldhaber SZ; Lindström S; Kabrhel C
Thromb Haemost; 2016 Sep; 116(4):705-13. PubMed ID: 27305932
[TBL] [Abstract][Full Text] [Related]
8. Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
Jarvis KB; Nielsen RL; Gupta R; Hede FD; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Saks K; Trakymiene SS; Tuckuviene R; Tulstrup M; ; Ruud E; Schmiegelow K; LeBlanc M
Thromb Res; 2020 Dec; 196():15-20. PubMed ID: 32818716
[TBL] [Abstract][Full Text] [Related]
9. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
[TBL] [Abstract][Full Text] [Related]
10. Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness.
Tavares V; Pinto R; Assis J; Pereira D; Medeiros R
Data Brief; 2020 Jun; 30():105399. PubMed ID: 32258274
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the effect of the genotype on postoperative venous thromboembolism risk in 140,831 surgical patients.
A Christensen M; Bonde A; Sillesen M
Ann Med Surg (Lond); 2021 Nov; 71():102938. PubMed ID: 34777790
[TBL] [Abstract][Full Text] [Related]
13. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.
Dennis J; Medina-Rivera A; Truong V; Antounians L; Zwingerman N; Carrasco G; Strug L; Wells P; Trégouët DA; Morange PE; Wilson MD; Gagnon F
Genet Epidemiol; 2017 Jul; 41(5):455-466. PubMed ID: 28421636
[TBL] [Abstract][Full Text] [Related]
14. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.
Archer NP; Perez-Andreu V; Scheurer ME; Rabin KR; Peckham-Gregory EC; Plon SE; Zabriskie RC; De Alarcon PA; Fernandez KS; Najera CR; Yang JJ; Antillon-Klussmann F; Lupo PJ
Cancer; 2016 Dec; 122(23):3697-3704. PubMed ID: 27529658
[TBL] [Abstract][Full Text] [Related]
15. Identification of unique venous thromboembolism-susceptibility variants in African-Americans.
Heit JA; Armasu SM; McCauley BM; Kullo IJ; Sicotte H; Pathak J; Chute CG; Gottesman O; Bottinger EP; Denny JC; Roden DM; Li R; Ritchie MD; de Andrade M
Thromb Haemost; 2017 Apr; 117(4):758-768. PubMed ID: 28203683
[TBL] [Abstract][Full Text] [Related]
16. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
Trégouët DA; Heath S; Saut N; Biron-Andreani C; Schved JF; Pernod G; Galan P; Drouet L; Zelenika D; Juhan-Vague I; Alessi MC; Tiret L; Lathrop M; Emmerich J; Morange PE
Blood; 2009 May; 113(21):5298-303. PubMed ID: 19278955
[TBL] [Abstract][Full Text] [Related]
17. Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.
Zhang H; Liu AP; Devidas M; Lee SH; Cao X; Pei D; Borowitz M; Wood B; Gastier-Foster JM; Dai Y; Raetz E; Larsen E; Winick N; Bowman WP; Karol S; Yang W; Martin PL; Carroll WL; Pui CH; Mullighan CG; Evans WE; Cheng C; Hunger SP; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2021 Apr; 113(4):408-417. PubMed ID: 32894760
[TBL] [Abstract][Full Text] [Related]
18. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
[TBL] [Abstract][Full Text] [Related]
20. Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism.
Rühle F; Witten A; Barysenka A; Huge A; Arning A; Heller C; Krümpel A; Mesters R; Franke A; Lieb W; Riemenschneider M; Hiersche M; Limperger V; Nowak-Göttl U; Stoll M
Blood; 2017 Feb; 129(6):783-790. PubMed ID: 28011674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
